Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation

Naohide Watanabe, Hideaki Nakajima, Hidenori Suzuki, Atsushi Oda, Yumiko Matsubara, Masaaki Moroi, Yasuo Terauchi, Takashi Kadowaki, Harumi Suzuki, Shigeo Koyasu, Yasuo Ikeda, Makoto Handa

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Phosphoinositide 3-kinases (PI3Ks), a family of lipid kinases comprising 3 classes with multiple isoforms, have been shown to participate in different phases of platelet signaling. To investigate the roles that enzymes play in platelet function in vivo and determine which isoforms are important for particular signaling events, we analyzed platelet function of gene knockout mice deficient in the p85α regulatory subunit of heterodimeric class IA PI3K. The kinase activity of p85α-/- platelets was only 5% of the activity of platelets from wild-type littermates. Platelet aggregation induced by adenosine diphosphate (ADP), thrombin, U46619, phorbol 12-myristate 13-acetate (PMA), or botrocetin was not defective in p85α-/- mice, compared with wild-type animals. In contrast, aggregation induced by collagen and collagen-related peptide (CRP) was partially but readily impaired in p85α-/- mice. Both P-selectin expression and fibrinogen binding in response to CRP were also decreased to a similar extent in p85α-/- platelets. Platelets from p85α-/- mice appeared to spread poorly over a CRP-coated surface with intact filopodial protrusions. Significant attenuation of CRP-induced tyrosine phosphorylation in known PI3K effectors such as Btk, Tec, PKB/Akt, and phospholipase Cγ2 were observed with p85α-/- platelets, whereas no alteration was noted in upstream molecules of Syk, LAT, and SLP-76. Considered as a whole, these results provide the first genetic evidence that PI3K p85α plays a significant role in platelet function, almost exclusively in the glycoprotein (GP) VI/Fc receptor γ chain complex-mediated signaling pathway.

Original languageEnglish
Pages (from-to)541-548
Number of pages8
JournalBlood
Volume102
Issue number2
DOIs
Publication statusPublished - 2003 Jul 15
Externally publishedYes

Fingerprint

1-Phosphatidylinositol 4-Kinase
Platelets
Phosphatidylinositols
Glycoproteins
Phosphotransferases
Blood Platelets
Phenotype
Protein Isoforms
Agglomeration
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Gene Knockout Techniques
Wild Animals
P-Selectin
Fc Receptors
Phospholipases
Phosphorylation
Platelet Aggregation
Knockout Mice
Thrombin
Adenosine Diphosphate

ASJC Scopus subject areas

  • Hematology

Cite this

Watanabe, N., Nakajima, H., Suzuki, H., Oda, A., Matsubara, Y., Moroi, M., ... Handa, M. (2003). Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. Blood, 102(2), 541-548. https://doi.org/10.1182/blood-2002-11-3327

Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. / Watanabe, Naohide; Nakajima, Hideaki; Suzuki, Hidenori; Oda, Atsushi; Matsubara, Yumiko; Moroi, Masaaki; Terauchi, Yasuo; Kadowaki, Takashi; Suzuki, Harumi; Koyasu, Shigeo; Ikeda, Yasuo; Handa, Makoto.

In: Blood, Vol. 102, No. 2, 15.07.2003, p. 541-548.

Research output: Contribution to journalArticle

Watanabe, N, Nakajima, H, Suzuki, H, Oda, A, Matsubara, Y, Moroi, M, Terauchi, Y, Kadowaki, T, Suzuki, H, Koyasu, S, Ikeda, Y & Handa, M 2003, 'Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation', Blood, vol. 102, no. 2, pp. 541-548. https://doi.org/10.1182/blood-2002-11-3327
Watanabe, Naohide ; Nakajima, Hideaki ; Suzuki, Hidenori ; Oda, Atsushi ; Matsubara, Yumiko ; Moroi, Masaaki ; Terauchi, Yasuo ; Kadowaki, Takashi ; Suzuki, Harumi ; Koyasu, Shigeo ; Ikeda, Yasuo ; Handa, Makoto. / Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. In: Blood. 2003 ; Vol. 102, No. 2. pp. 541-548.
@article{b0886beed0774f7db746b9a711d36f51,
title = "Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation",
abstract = "Phosphoinositide 3-kinases (PI3Ks), a family of lipid kinases comprising 3 classes with multiple isoforms, have been shown to participate in different phases of platelet signaling. To investigate the roles that enzymes play in platelet function in vivo and determine which isoforms are important for particular signaling events, we analyzed platelet function of gene knockout mice deficient in the p85α regulatory subunit of heterodimeric class IA PI3K. The kinase activity of p85α-/- platelets was only 5{\%} of the activity of platelets from wild-type littermates. Platelet aggregation induced by adenosine diphosphate (ADP), thrombin, U46619, phorbol 12-myristate 13-acetate (PMA), or botrocetin was not defective in p85α-/- mice, compared with wild-type animals. In contrast, aggregation induced by collagen and collagen-related peptide (CRP) was partially but readily impaired in p85α-/- mice. Both P-selectin expression and fibrinogen binding in response to CRP were also decreased to a similar extent in p85α-/- platelets. Platelets from p85α-/- mice appeared to spread poorly over a CRP-coated surface with intact filopodial protrusions. Significant attenuation of CRP-induced tyrosine phosphorylation in known PI3K effectors such as Btk, Tec, PKB/Akt, and phospholipase Cγ2 were observed with p85α-/- platelets, whereas no alteration was noted in upstream molecules of Syk, LAT, and SLP-76. Considered as a whole, these results provide the first genetic evidence that PI3K p85α plays a significant role in platelet function, almost exclusively in the glycoprotein (GP) VI/Fc receptor γ chain complex-mediated signaling pathway.",
author = "Naohide Watanabe and Hideaki Nakajima and Hidenori Suzuki and Atsushi Oda and Yumiko Matsubara and Masaaki Moroi and Yasuo Terauchi and Takashi Kadowaki and Harumi Suzuki and Shigeo Koyasu and Yasuo Ikeda and Makoto Handa",
year = "2003",
month = "7",
day = "15",
doi = "10.1182/blood-2002-11-3327",
language = "English",
volume = "102",
pages = "541--548",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation

AU - Watanabe, Naohide

AU - Nakajima, Hideaki

AU - Suzuki, Hidenori

AU - Oda, Atsushi

AU - Matsubara, Yumiko

AU - Moroi, Masaaki

AU - Terauchi, Yasuo

AU - Kadowaki, Takashi

AU - Suzuki, Harumi

AU - Koyasu, Shigeo

AU - Ikeda, Yasuo

AU - Handa, Makoto

PY - 2003/7/15

Y1 - 2003/7/15

N2 - Phosphoinositide 3-kinases (PI3Ks), a family of lipid kinases comprising 3 classes with multiple isoforms, have been shown to participate in different phases of platelet signaling. To investigate the roles that enzymes play in platelet function in vivo and determine which isoforms are important for particular signaling events, we analyzed platelet function of gene knockout mice deficient in the p85α regulatory subunit of heterodimeric class IA PI3K. The kinase activity of p85α-/- platelets was only 5% of the activity of platelets from wild-type littermates. Platelet aggregation induced by adenosine diphosphate (ADP), thrombin, U46619, phorbol 12-myristate 13-acetate (PMA), or botrocetin was not defective in p85α-/- mice, compared with wild-type animals. In contrast, aggregation induced by collagen and collagen-related peptide (CRP) was partially but readily impaired in p85α-/- mice. Both P-selectin expression and fibrinogen binding in response to CRP were also decreased to a similar extent in p85α-/- platelets. Platelets from p85α-/- mice appeared to spread poorly over a CRP-coated surface with intact filopodial protrusions. Significant attenuation of CRP-induced tyrosine phosphorylation in known PI3K effectors such as Btk, Tec, PKB/Akt, and phospholipase Cγ2 were observed with p85α-/- platelets, whereas no alteration was noted in upstream molecules of Syk, LAT, and SLP-76. Considered as a whole, these results provide the first genetic evidence that PI3K p85α plays a significant role in platelet function, almost exclusively in the glycoprotein (GP) VI/Fc receptor γ chain complex-mediated signaling pathway.

AB - Phosphoinositide 3-kinases (PI3Ks), a family of lipid kinases comprising 3 classes with multiple isoforms, have been shown to participate in different phases of platelet signaling. To investigate the roles that enzymes play in platelet function in vivo and determine which isoforms are important for particular signaling events, we analyzed platelet function of gene knockout mice deficient in the p85α regulatory subunit of heterodimeric class IA PI3K. The kinase activity of p85α-/- platelets was only 5% of the activity of platelets from wild-type littermates. Platelet aggregation induced by adenosine diphosphate (ADP), thrombin, U46619, phorbol 12-myristate 13-acetate (PMA), or botrocetin was not defective in p85α-/- mice, compared with wild-type animals. In contrast, aggregation induced by collagen and collagen-related peptide (CRP) was partially but readily impaired in p85α-/- mice. Both P-selectin expression and fibrinogen binding in response to CRP were also decreased to a similar extent in p85α-/- platelets. Platelets from p85α-/- mice appeared to spread poorly over a CRP-coated surface with intact filopodial protrusions. Significant attenuation of CRP-induced tyrosine phosphorylation in known PI3K effectors such as Btk, Tec, PKB/Akt, and phospholipase Cγ2 were observed with p85α-/- platelets, whereas no alteration was noted in upstream molecules of Syk, LAT, and SLP-76. Considered as a whole, these results provide the first genetic evidence that PI3K p85α plays a significant role in platelet function, almost exclusively in the glycoprotein (GP) VI/Fc receptor γ chain complex-mediated signaling pathway.

UR - http://www.scopus.com/inward/record.url?scp=0037818568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037818568&partnerID=8YFLogxK

U2 - 10.1182/blood-2002-11-3327

DO - 10.1182/blood-2002-11-3327

M3 - Article

VL - 102

SP - 541

EP - 548

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -